Augmenix announces first prostate cancer patient treated with SpaceOAR hydrogel in New Zealand

Press releases may be edited for formatting or style | June 22, 2017 Rad Oncology

KKC sets a new standard in New Zealand with its innovative design, cutting edge technology, and personalised patient care. Treatment is available to public and privately funded patients. For more information, go to www.kathleenkilgourcentre.co.nz

1) Hamstra D, et al. Continued Benefit to Rectal Separation for Prostate RT: Final Results of a Phase III Trial. Int J Radiation Oncol Biol Phys, Vol. 97, No. 5, pp. 976-985, 2017

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

2) Hamstra D, et al. Evaluation of sexual function on a randomized trial of a prostate rectal spacer. J Clin Oncol 35, 2017 (suppl 6S; abstract 69)

Back to HCB News



You Must Be Logged In To Post A Comment Sign In If you've already created an account, use your email address and password to sign in using the form below. Login Problems: Click here if you are having login issues. Email address: Password: Forgot your password? Login Problems? View our Legal Notice and Privacy Notice Register Registration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now!